You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

Alkermes

Alkermes Inc. 

852 Winter Street
Waltham, MA 02451

https://www.alkermes.com/
https://www.vivitrolhcp.com/
https://landing.alkermes.info/Alaska-Chapter--AKOMA-CME-2021-Scientific-Meeting.html

Michael S Eldridge, MBA, EMT-P, MICP
Michael.Eldridge@alkermes.com
(907) 229-7064


Who We Are

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.

For more information, please visit Alkermes' website at www.alkermes.com.